Hyperpolarized 13 C and 31 P MRS detects differences in cardiac energetics, metabolism, and function in obesity, and responses following treatment

Lewis, AJM; Dodd, MS; Sourdon, J; Lygate, CA; Clarke, K; Neubauer, S; Tyler, DJ; Rider, OJ

Journal article

Hyperpolarized 13 C and 31 P MRS detects differences in cardiac energetics, metabolism, and function in obesity, and responses following treatment

Abstract:: Obesity is associated with important changes in cardiac energetics and function, and an increased risk of adverse cardiovascular outcomes. Multi‐nuclear MRS and MRI techniques have the potential to provide a comprehensive non‐invasive assessment of cardiac metabolic perturbation in obesity. A rat model of obesity was created by high‐fat diet feeding. This model was characterized using in vivo hyperpolarized [1‐13C]pyruvate and [2‐13C]pyruvate MRS, echocardiography and perfused heart 31P MRS. Two groups of obese rats were subsequently treated with either caloric restriction or the glucagon‐like peptide‐1 analogue/agonist liraglutide, prior to reassessment. The model recapitulated cardiovascular consequences of human obesity, including mild left ventricular hypertrophy, and diastolic, but not systolic, dysfunction. Hyperpolarized 13C and 31P MRS demonstrated that obesity was associated with reduced myocardial pyruvate dehydrogenase flux, altered cardiac tricarboxylic acid (TCA) cycle metabolism, and impaired myocardial energetic status (lower phosphocreatine to adenosine triphosphate ratio and impaired cardiac ΔG~ATP). Both caloric restriction and liraglutide treatment were associated with normalization of metabolic changes, alongside improvement in cardiac diastolic function. In this model of obesity, hyperpolarized 13C and 31P MRS demonstrated abnormalities in cardiac metabolism at multiple levels, including myocardial substrate selection, TCA cycle, and high‐energy phosphorus metabolism. Metabolic changes were linked with impairment of diastolic function and were reversed in concert following either caloric restriction or liraglutide treatment. With hyperpolarized 13C and 31P techniques now available for human use, the findings support a role for multi‐nuclear MRS in the development of new therapies for obesity.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Lewis, A. J. M., Dodd, M. S., Sourdon, J., Lygate, C. A., Clarke, K., Neubauer, S., Tyler, D. J., & Rider, O. J. (2024). Hyperpolarized 13 C and 31 P MRS detects differences in cardiac energetics, metabolism, and function in obesity, and responses following treatment. NMR in Biomedicine.

MLA Style

Lewis, A. JM, et al. “Hyperpolarized 13 C and 31 P MRS Detects Differences in Cardiac Energetics, Metabolism, and Function in Obesity, and Responses Following Treatment.” NMR in Biomedicine, Wiley, 2024.

Chicago Style

Lewis, AJM, MS Dodd, J Sourdon, CA Lygate, K Clarke, S Neubauer, DJ Tyler, and OJ Rider. 2024. “Hyperpolarized 13 C and 31 P MRS Detects Differences in Cardiac Energetics, Metabolism, and Function in Obesity, and Responses Following Treatment.” NMR in Biomedicine.
Share
Print